BioSpace News Archive

Concord Medical Services Holdings Limited announced that investment institutions led by CICC Capital Management Company Limited will make a strategic investment in Concord Medical’s subsidiary, Beijing Meizhong Jiahe Hospital Management Co., Ltd. (“Meizhong Jiahe”).

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV:ATE, OTCQB:ATBPF), a leader in developing safer therapeutics for pain and inflammation that recently announced a successful Phase 2B clinical trial demonstrating the gastrointestinal safety of its lead drug, reports that the Company now has a significantly augmented balance sheet.

Organization Calls on Federal, State and County Governments to Implement Programs that Better Support Victims of Non-Fatal Opioid Overdose

Ms. Rhoads brings over 20 years of corporate and financial management expertise in the life sciences and healthcare industry.

Grant will be used to further product development, clinical studies, production scale-up, marketing and expanding the Company’s current intellectual property.

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC who are not candidates for surgery.

Ciox announces its partnership with Trevelino/Keller, a full-service public relations and digital marketing agency.

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Pint Pharma International S.A., a company focused on innovative treatments for patients in Latin America with cancer, rare diseases, and genetic disorders, have entered into an agreement for Pint Pharma to commercialize NERLYNX® (neratinib) in Argentina, Brazil, Chile, Colombia, Mexico and the rest of Latin America.

Cardinal Health plans to release third-quarter financial results for its fiscal year 2018 on May 3 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

At the National Kidney Foundation’s (NKF) 27th Annual Spring Clinical Meetings, the foundation will bestow its highest honors to some of the nation’s leading kidney disease researchers, clinicians, patient advocates, government officials and corporate partners.